Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
复制标题
DOI：
10.1016/j.juro.2007.09.003
复制
发表时间：
2007-12-01
影响因子：
6.6
通讯作者：
Schellhammer, Paul F.
中科院分区：
文献类型：
--
作者：
Hall, M. Craig;Chang, Sam S.;Schellhammer, Paul F.
美国每年诊断出超过60，000例新的膀胱癌病例，每年约有13，000人死亡。1在最初诊断时，大多数膀胱癌是非肌层浸润性的（也称为“浅表性”）-即，非浸润性的且局限于粘膜或浸润固有层但尚未侵犯逼尿肌。1999年，AUA发表了一份关于非肌肉管理的报告，
More than 60,000 new cases of bladder cancer are diagnosed each year in the US accounting for approximately 13,000 deaths annually. 1 When initially diagnosed, most bladder cancers are nonmuscle invasive (also referred to as “superficial”)–ie, either noninvasive and confined to the mucosa or invading the lamina propria but not yet invading the detrusor muscle. In 1999, the AUA published a report on the Management of Non-Muscle-